CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Par Pharmaceutical, Inc. v. Alkem Laboratories Ltd.

2:23-cv-00400

Overview

Case Number 2:23-cv-00400
Filing Date 2023-09-01
Status Terminated
Termination Date 2024-12-10
Court District Court, E.D. Texas (txed)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Both

Parties

Defendant

Alkem Laboratories Ltd. Operating Company

Represented By

4 Attorneys Listed

Wesley Edenton Weeks

Wiley Rein LLP

Tel: +1 (202) 719-7569
Fax: +1 (202) 719-7049

1776 K Street NW, Washington, DC 20006

A. Neal Seth

Wiley Rein LLP

Tel: +1 (202) 719-7000

2050 M Street, NW, Washington, DC 20036

Teresa Marie Summers

Wiley Rein LLP

Tel: +1 (202) 664-0926

District of Columbia, 2050 M Street NW

Melissa Richards Smith

Gillam & Smith, LLP

Tel: +1 (903) 934-8450
Fax: +1 (903) 934-9257

303 South Washington Avenue, Marshall, TX 75670

Plaintiff

Endo Par Innovation Company, LLC Operating Company

Represented By

8 Attorneys Listed

Sharon K Gagliardi

Dechert LLP - Philadelphia

Tel: +1 (215) 994-4000
Fax: +1 (215) 655-2278

2929 Arch St, Cira Centre

Shyam Shanker

Dechert LLP

Tel: +1 (704) 339-3160

300 South Tryon Street, Suite 800

Robert D Rhoad

Dechert LLP - New Jersey

Tel: +1 (609) 955-3269
Fax: +1 (609) 955-3259

902 Carnegie Center, Suite 500

Luke M. Reilly

Dechert LLP - Philadelphia

Tel: +1 (215) 994-2194
Fax: +1 (215) 994-2222

2929 Arch St, Cira Centre

Jonathan Loeb

Dechert, LLP

Tel: +1 (650) 813-4995
Fax: +1 (650) 813-4848

3000 El Camino Real, Five Palo Alto Square, Suite 650

Brian Goldberg

Dechert LLP

Tel: +1 (215) 994-2143
Fax: +1 (215) 655-2143

Cira Centre, 2929 Arch Street

Martin Jay Black

Dechert LLP - Philadelphia

Tel: +1 (215) 994-2664
Fax: +1 (215) 655-2664

2929 Arch St, Cira Centre

Andrea Leigh Fair

Miller Fair Henry PLLC

Tel: +1 (903) 757-6400

1507 Bill Owens Parkway, Longview, TX 75604

Par Pharmaceutical, Inc. Operating Company

Represented By

8 Attorneys Listed

Sharon K Gagliardi

Dechert LLP - Philadelphia

Tel: +1 (215) 994-4000
Fax: +1 (215) 655-2278

2929 Arch St, Cira Centre

Shyam Shanker

Dechert LLP

Tel: +1 (704) 339-3160

300 South Tryon Street, Suite 800

Robert D Rhoad

Dechert LLP - New Jersey

Tel: +1 (609) 955-3269
Fax: +1 (609) 955-3259

902 Carnegie Center, Suite 500

Luke M. Reilly

Dechert LLP - Philadelphia

Tel: +1 (215) 994-2194
Fax: +1 (215) 994-2222

2929 Arch St, Cira Centre

Jonathan Loeb

Dechert, LLP

Tel: +1 (650) 813-4995
Fax: +1 (650) 813-4848

3000 El Camino Real, Five Palo Alto Square, Suite 650

Brian Goldberg

Dechert LLP

Tel: +1 (215) 994-2143
Fax: +1 (215) 655-2143

Cira Centre, 2929 Arch Street

Martin Jay Black

Dechert LLP - Philadelphia

Tel: +1 (215) 994-2664
Fax: +1 (215) 655-2664

2929 Arch St, Cira Centre

Andrea Leigh Fair

Miller Fair Henry PLLC

Tel: +1 (903) 757-6400

1507 Bill Owens Parkway, Longview, TX 75604

Consol Defendant

Mankind Pharma Limited NPE (University / Research)

Represented By

4 Attorneys Listed

M. Brett Johnson

Winston & Strawn LLP - Dallas

Tel: +1 (214) 453-6500
Fax: +1 (214) 453-6400

2121 N Pearl Street, Suite 900

Patrick David Clark

Winston & Strawn/Chicago

Tel: +1 (214) 453-6492

Winston & Strawn/Chicago, 2121 N. Pearl Street

George C. Lombardi

Winston & Strawn LLP - Chicago

Tel: +1 (312) 558-5969
Fax: +1 (312) 558-5700

35 West Wacker Drive, Suite 4200

Rex Andrew Mann

Winston & Strawn/Chicago

Tel: +1 (214) 453-6412
Fax: +1 (214) 453-6400

Winston & Strawn/Chicago, 2121 N. Pearl Street

Technical Advisor

David Keyzer NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, E.D. Texas (txed)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2023-09-01
2:23-cv-00399

Par Pharmaceutical, Inc. v. Mankind Pharma Limited <b><font color="red">PURSUANT TO COURT ORDER, DOCKET IN LEAD CASE 2:23CV400</font></b>

U.S. Family Sibling (["US11717524"])
Status: TXED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11717524
Varenicline compound and process of manufacture thereof
Filed: 2022-09-09
Issued: 2023-08-08
Active (15.4 yrs remaining)
Expires: 2042-04-15
US11779587
Vareniciline compound and process of manufacture thereof
Filed: 2022-12-30
Issued: 2023-10-10
Active (15.4 yrs remaining)
Expires: 2042-04-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

60

Dispositive

24

Granted

17

Denied

0

Pending / Review

25

Motions by Category

Procedural / Extension Motion 26 Motion for Preliminary Injunction / TRO 10 Motion to Transfer Venue (28 U.S.C. § 1404) 14 Claim Construction / Markman Filing 8 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. § 1404) Moot / Terminated
MEMORANDUM ORDER re 12 MOTION to Quash SERVICE AND DISMISS THE COMPLAINT OR IN THE ALTERNATIVE TRANSFER VENUE filed by Alkem Laboratories Ltd.. (Motion(s) 12 te...
Entry #76 • 2024-09-11 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
RESPONSE to Defendant's Motion to Transfer Venue (Plaintiffs' Surreply Brief in Opposition) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc.....
Entry #34 • 2023-11-02 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
SUR-REPLY to Reply to Response to Motion re 12 MOTION to Quash SERVICE AND DISMISS THE COMPLAINT OR IN THE ALTERNATIVE TRANSFER VENUE filed by Endo Par Innovati...
Entry #32 • 2023-10-17 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Granted
ORDER granting 30 UNOPPOSED MOTION for Extension of Time to File Response/Reply as to 12 MOTION to Quash SERVICE AND DISMISS THE COMPLAINT OR IN THE ALTERNATIVE...
Entry #31 • 2023-10-08 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Granted
UNOPPOSED MOTION for Extension of Time to File Response/Reply as to 12 MOTION to Quash SERVICE AND DISMISS THE COMPLAINT OR IN THE ALTERNATIVE TRANSFER VENUE (t...
Entry #30 • 2023-10-05 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
REPLY to Response to Motion re 12 MOTION to Quash SERVICE AND DISMISS THE COMPLAINT OR IN THE ALTERNATIVE TRANSFER VENUE filed by Alkem Laboratories Ltd.. (Atta...
Entry #26 • 2023-09-28 Document →

Docket Entries

(157 total)
Pleading / Complaint

COMPLAINT against Alkem Laboratories Ltd. ( Filing fee $ 402 receipt number ATXEDC-9685252.), filed by Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1 -US11717524, # 3 Exhibit 2 - Control of Nitrosamine Impurities in Human Drugs, Guidance for Industry, U.S. Food and Drug Administration Center for Drug Evaluation and Research (Feb. 2021, Rev. 1), # 4 Exhibit 3 - Laboratory analysis of varenicline products, FDA Feb. 8, 2022, # 5 Exhibit 14 - First Notice Letter, # 6 Exhibit 15 - Second Notice Letter, # 7 Exhibit 16 - Third Notice Letter, # 8 Exhibit 17 - Drugs@FDA Website, # 9 Exhibit 18 - Fourth Notice Letter)(Fair, Andrea) (Entered: 09/01/2023)

Entry #1 • 2023-09-01
1

Fed. R. Civ. P. 7.1(a)(1) Disclosure Statement filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. identifying Other Affiliate Endo International PLC for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc.. (Fair, Andrea) (Entered: 09/01/2023)

Entry #2 • 2023-09-01
1

Notice of Filing of Patent/Trademark Form (AO 120). AO 120 mailed to the Director of the U.S. Patent and Trademark Office. (Fair, Andrea) (Entered: 09/01/2023)

Entry #3 • 2023-09-01
1
Procedural / Extension Motion Granted

MOTION to Seal (For Leave to File Under Seal) by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc.. (Attachments: # 1 Proposed Order)(Fair, Andrea) (Entered: 09/01/2023)

Entry #4 • 2023-09-01
1
Motion for Preliminary Injunction / TRO Moot / Terminated

WITHDRAWN PER ORDER 22 SEALED MOTION PLAINTIFFS MOTION FOR EXPEDITED DISCOVERY AND TEMPORARY RESTRAINING ORDER by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc.. (Attachments: # 1 Proposed Order, # 2 Affidavit/Declaration - Bradley, # 3 Affidavit/Declaration - Jarosz, # 4 Affidavit/Declaration - Dodds, # 5 Affidavit/Declaration - Rhoad, # 6 Exhibit 1, # 7 Exhibit 2, # 8 Exhibit 3, # 9 Exhibit 14, # 10 Exhibit 15, # 11 Exhibit 16, # 12 Exhibit 17, # 13 Exhibit 18, # 14 Exhibit 19, # 15 Exhibit 20)(Fair, Andrea) Modified on 9/25/2023 (nkl, ). (Entered: 09/01/2023)

Entry #5 • 2023-09-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc